Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: Data from an HIV cohort study in India

Global Health Action

Volumn 6, Issue 1, 2013, Pages

  Alvarez Uria, Gerardo ^a   Naik, Praveen K ^a   Pakam, Raghavakalyan ^a   Midde, Manoranjan ^a  

^a Rural Development Trust Hospital   (India)

Author keywords

Attrition; Developing countries; Highly active antiretroviral therapy; Lost to follow up; Mortality; Rural health

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AGE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; FEMALE; FOLLOW UP; HIV INFECTIONS; HUMAN; INDIA; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; MORTALITY; PREVALENCE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; YOUNG ADULT; ARTICLE; ATTRITION; DEVELOPING COUNTRY; HEALTH; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; STATISTICS;

ADULT; AGE FACTORS; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INDIA; LOST TO FOLLOW-UP; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

ATTRITION; DEVELOPING COUNTRIES; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; LOST TO FOLLOW UP; MORTALITY; RURAL HEALTH;

EID: 84886305675     PISSN: None     EISSN: 16549880     Source Type: Journal    
DOI: 10.3402/gha.v6i0.21682     Document Type: Article

References (37)

1. UNAIDS (2012). UNAIDS report on the global AIDS epidemic. Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_UNAIDS_Global_Report_2012_en.pdf [cited 5 Dec 2012].
2. Eaton JW, Johnson LF, Salomon JA, Bärnighausen T, Bendavid E, Bershteyn A, et al. HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med 2012; 9: e1001245.
3. National AIDS Control Organisation, India (2013). HIV estimates 2012. Technical Report. Available from: www.nacoonline.org/upload/Surveillance/Reports%20&%20Publication/Technical% 20Report%20-%20India%20HIV%20Estimates%202012.pdf [cited 22 Jul 2013].
4. Dandona L, Lakshmi V, Sudha T, Kumar GA, Dandona R. A population-based study of human immunodeficiency virus in south India reveals major differences from sentinel surveillancebased estimates. BMC Med 2006; 4: 31
5. Perkins JM, Khan KT, Subramanian SV. Patterns and distribution of HIV among adult men and women in India. PLoS One 2009; 4: e5648.
6. Alvarez-Uria G, Midde M, Pakam R, Naik PK. Gender differences, routes of transmission, socio-demographic characteristics and prevalence of HIV related infections of adults and children in an HIV cohort from a rural district of India. Infect Dis Rep 2012; 4: e19.
7. Alvarez-Uria G, Midde M, Naik PK. Trends and risk factors for HIV infection among young pregnant women in rural India. Int J Infect Dis 2012; 16: e121-3.
8. National AIDS Control Organisation (2013). Annual Report 2012-13. Available from: http://www.nacoonline.org/upload/Publication/Annual%20Report/Annual%20report%202012-13_English.pdf [cited 22 Jul 2013].
9. Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health 2010; 15(Suppl 1): 1-15.
10. Sharma SK, Dhooria S, Prasad K, George N, Ranjan S, Gupta D, et al. Outcomes of antiretroviral therapy in a northern Indian urban clinic. Bull World Health Organ 2010; 88: 222-6.
11. Office of the Registrar General & Census Commissioner, India. Census of India. 2011.
12. National AIDS Control Organisation (2012). HIV sentinel surveillance 2010-11. A Technical Brief. Available from: http://naco.gov.in/upload/Surveillance/Reports%20&%20Publication/HSS%202010-11_Technical%20Brief_30%20Nov%2012.pdf [cited 21 Jan 2013].
13. National AIDS Control Organisation. Ministry of Health & Family Welfare Government of India (2007). Antiretroviral therapy guidelines for HIV infected adults and adolescents including post-exposure. Available from: http://www.nacoonline.org/About_NACO/Policy__Guidelines/Policies__Guidelines_Table_for_download/[cited 1 Sep 2011].
14. Panos. Antiretroviral drugs for all? Obstacles in accessing treatment lessons from India. 2007. Available from: http://www. panossouthasia.org/pdf/Antiretrovirals.pdf [cited 27 May 2012].
15. WHO (2006). Antiretroviral therapy for HIV infection in adults and adolescents. Available from: http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf [cited 27 May 2012].
16. Gang IN, Sen K, Yun MS. Caste, ethnicity, and poverty in rural India. Bonn, Germany: IZA; 2002.
17. Alvarez-Uria G, MiddeM, Naik PK. Socio-demographic risk factors associated with HIV infection in patients seeking medical advice in a rural hospital of India. J Public health Res 2012; 1: e14.
18. Chi BH, Yiannoutsos CT, Westfall AO, Newman JE, Zhou J, Cesar C, et al. Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America. PLoS Med 2011; 8: e1001111.
19. Kleinbaum DG, Klein M. Survival analysis, a self-learning text. Second. New York, USA: Springer; 2005.
20. Royston P. Multiple imputation of missing values: further update of ice, with an emphasis on categorical variables. Stata J 2009; 9: 466-77.
21. Coviello V, Boggess M. Cumulative incidence estimation in the presence of competing risks. Stata J 2004; 4: 103-12.
22. Fatti G, Meintjes G, Shea J, Eley B, Grimwood A. Improved survival and antiretroviral treatment outcomes in adults receiving community-based adherence support: 5-year results from a multicentre cohort study in South Africa. J Acquir Immune Defic Syndr 2012; 61: e50-8.
23. Fregonese F, Collins IJ, Jourdain G, Lecoeur S, Cressey TR, Ngo-Giang-Houng N, et al. Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in Thailand. J Acquir Immune Defic Syndr 2012; 60: 91-8.
24. Zhu H, Napravnik S, Eron J, Cole S, Ma Y, Wohl D, et al. Attrition among human immunodeficiency virus (HIV) - infected patients initiating antiretroviral therapy in China, 2003-2010. PLoS One 2012; 7: e39414.
25. National AIDS Control Organisation (2012). Operational guidelines for ART services. Available from: http://www.nacoonline.org/upload/Publication/Treatment%20Care%20and%20support/Operational%20guidelines%20for%20ART%20services.pdf [cited 22 Jul 2013].
26. World Health Organization (2013). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Available from: http://www.who.int/hiv/pub/guidelines/arv2013/en/index.html [cited 20 Jul 2013].
27. Alvarez-Uria G, Midde M, Pakam R, Kannan S, Bachu L, Naik PK. Factors associated with late presentation of HIV and estimation of antiretroviral treatment need according to CD4 lymphocyte count in a resource-limited setting: data from an HIV cohort study in India. Interdiscip Perspect Infect Dis 2012; 2012: 293795.
28. Alvarez-Uria G. Factors associated with delayed entry into HIV medical care after HIV diagnosis in a resource-limited setting: data from a cohort study in India. Peer J 2013; 1: e90.
29. Boyles TH, Wilkinson LS, Leisegang R, Maartens G. Factors influencing retention in care after starting antiretroviral therapy in a rural South African programme. PLoS One 2011; 6: e19201.
30. Brinkhof MWG, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One 2009; 4: e5790.
31. Ware NC, Wyatt MA, Geng EH, Kaaya SF, Agbaji OO, Muyindike WR, et al. Toward an understanding of disengagement from HIV treatment and care in sub-Saharan Africa: a qualitative study. PLoS Med 2013; 10: e1001369.
32. Franke MF, Kaigamba F, Socci AR, Hakizamungu M, Patel A, Bagiruwigize E, et al. Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda. Clin Infect Dis 2013; 56: 1319-26.
33. Bagchi S. Telemedicine in rural India. PLoS Med 2006; 3: e82.
34. Srikantiah P, Ghidinelli M, Bachani D, Chasombat S, Daoni E, Mustikawati DE, et al. Scale-up of national antiretroviral therapy programs: progress and challenges in the Asia Pacific region. AIDS 2010; 24(Suppl 3): S62-71.
35. Alvarez-Uria G, Naik PK, Pakam R, Bachu L, Midde M. Natural history and factors associated with early and delayed mortality in HIV infected patients treated of tuberculosis under directly observed treatment short course (DOTS) strategy: a prospective cohort study in India. Interdiscip Perspect Infect Dis 2012; 2012: 502012.
36. Koenig SP, Riviere C, Leger P, Joseph P, Severe P, Parker K, et al. High mortality among patients with AIDS who received a diagnosis of tuberculosis in the first 3 months of antiretroviral therapy. Clin Infect Dis 2009; 48: 829-31.
37. Wubshet M, Berhane Y, Worku A, Kebede Y. Death and seeking alternative therapy largely accounted for lost to follow-up of patients on ART in northwest Ethiopia: a community tracking survey. PLoS One 2013; 8: e59197.